Literature DB >> 4223779

Inhibition of fibrinolytic and thromboplastic activity by Trasylol.

C J Amris.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 4223779     DOI: 10.1111/j.1600-0609.1966.tb00622.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


× No keyword cloud information.
  9 in total

1.  Letter: Trasylol for pancreatitis.

Authors:  G L Haberland
Journal:  Br Med J       Date:  1974-11-23

Review 2.  Is there a place for proteinase inhibition? A review of the literature.

Authors:  G D Lister
Journal:  Postgrad Med J       Date:  1969-08       Impact factor: 2.401

Review 3.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

Review 4.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

5.  The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions.

Authors:  G L Haberland
Journal:  Klin Wochenschr       Date:  1978-04-01

6.  Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage.

Authors:  S E Patchett; D P O'Donoghue
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

7.  Aprotinin and growth of Walker 256 carcinosarcoma in the rat.

Authors:  A W Thomson; R G Pugh-Humphreys; C H Horne; D J Tweedle
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

8.  Alphavirus replication in cultured cells and infected animals is inhibited by antiproteinase agents.

Authors:  O P Zhirnov; A V Ovcharenko; E E Melnikova; A G Bukrinskaya
Journal:  Antiviral Res       Date:  1986-08       Impact factor: 5.970

9.  High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination.

Authors:  O P Zhirnov
Journal:  J Med Virol       Date:  1987-02       Impact factor: 2.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.